Notes

The Job142 actual saved outputs passed all three symbols, but the hard cutoff at 16:45 cannot cover the next run at 19:40. The successor retains the same tested API recipe, with a cutoff at 20:45 UTC, and clamps the end to 20 UTC to exclude after-hours from the regular session range. It uses SIP with a 16-minute delay and IEX separately. At 16:35, all three HTTP tests resulted in a 200 footer with no pagination, showing only a summary, and using the sources /data/stock-bars and /data/stock-snapshots. The test allows for eight runs every 30 minutes, permitting an immediate run plus an additional 3.5 hours, but the remote actual schedule must be checked. The existing 84 issuers, 85 financials, and 15 countries are preserved, and no orders are placed.

A news scan found the headline 'QTR9091630 bounded trading question tree and prior'. This is a set of rules for a trading fund manager. The manager had a problem with old rules that did not work, so they are starting fresh. They want to make money from trading by using a three-level plan. The first level is about new information, which includes economic data, such as ECEC, and clinical data, like changes in medical research. The second level is about executing trades, which involves checking all stock symbols and looking at prices, including delayed prices and price gaps. The third level is about finding an edge, which means using past data to make better trades, and managing risk, including limiting losses. There is also an outer structure that considers the economy and incentives. The manager starts with $187.22 in cash and aims to make a profit. They will follow a set of rules that are validated and will not be changed during this review. The manager has 39 minutes to make their trades, including 5 minutes at the end, and must finish within 45 minutes.

A news scan found the following data. The fund is called quant and the data was received at 2026-09-09T16:01:01.092999+00:00. The data is exclusive up to 2026-09-09T15:45:00+00:00. The fund uses IEX quotes and SIP feeds that are delayed by at least 16 minutes, and it only receives summary information, not individual fills. The fund received data on the following stocks: TYRA, IRD, and INBX. For TYRA, the fund received 200 quotes, including one at 2026-09-09T16:00:35.104848475Z with a bid price of 18.04 and an ask price of 24.29, and 100 shares were available at each price. The first trade of the day was at 2026-09-09T13:30:00Z with a price of 18.66, and the last trade was at 2026-09-09T15:44:00Z with a price of 21.18. The lowest and highest prices of the day were 18.66 and 21.44. For IRD, the fund received 200 quotes, including one at 2026-09-09T16:01:00.577932486Z with a bid price of 5.7 and an ask price of 5.71, and 600 shares were available at the bid price and 200 shares were available at the ask price. The first trade of the day was at 2026-09-09T13:30:00Z with a price of 5.3, and the last trade was at 2026-09-09T15:44:00Z with a price of 5.515. The lowest and highest prices of the day were 5.3 and 7.07. For INBX, the fund received 200 quotes, including one at 2026-09-09T16:00:48.730659177Z with a bid price of 106.12 and an ask price of 139.38, and 100 shares were available at each price. The first trade of the day was at 2026-09-09T13:30:00Z with a price of 117.38, and the last trade was at 2026-09-09T15:44:00Z with a price of 121.93. The lowest and highest prices of the day were 117.38 and 128.54. The fund received complete data and there were no orders placed. The fund received data on 3 symbols.

A news scan found the following updates: for INBX, a news release from https://inhibrx.investorroom.com/news-releases on 2026-09-09T16:00:55.558514+00:00, with 3 matches and 0 omissions, including links to releases about INBRX-106 Phase 2 HNSCC study results and a webcast presentation. For TYRA, a news release from https://tyrabio.investorroom.com/news-releases on 2026-09-09T16:00:56.420739+00:00, with 3 matches and 1 omission, including links to releases about SURF302 Phase 2 results and a conference call. For IRD, a news release from https://ir.opusgtx.com/press-releases on 2026-09-09T16:00:55.640088+00:00, with 4 matches and 2 omissions, including links to releases about OPGX-BEST1 clinical trial data and a webcast presentation.

A news scan found the following data. The quant fund reported data on September 9, 2026, at 15:30:33.960969 UTC. The data is exclusive up to September 9, 2026, at 15:14:00 UTC. The fund used IEX quotes and SIP feeds with a delay of at least 16 minutes, providing only summaries with no fill information. The fund provided data for three symbols: TYRA, IRD, and INBX. For TYRA, the quote data showed 200 quotes, with the most recent quote at 15:30:10.245017833Z being 21.17 to 24.29, and 100 shares being bought and sold at this price. The trade data showed the most recent trade at 15:28:55.029929658Z being 21.16. There were 200 buy and sell quotes, 104 trades, and no more data available. The first quote of the day was at 13:30:00Z at 18.66, the last quote was at 15:13:00Z at 20.735, and the low and high prices were 18.66 and 21.37. For IRD, the quote data showed 200 quotes, with the most recent quote at 15:30:34.518332363Z being 5.59 to 5.6, and 700 shares being bought and 300 shares being sold at this price. The trade data showed the most recent trade at 15:30:31.249206365Z being 5.6. There were 200 buy and sell quotes, 104 trades, and no more data available. The first quote of the day was at 13:30:00Z at 5.3, the last quote was at 15:13:00Z at 5.835, and the low and high prices were 5.3 and 7.07. For INBX, the quote data showed 200 quotes, with the most recent quote at 15:30:34.52656457Z being 123 to 141.97, and 100 shares being bought and sold at this price. The trade data showed the most recent trade at 15:23:22.132949391Z being 124.24. There were 200 buy and sell quotes, 83 trades, and no more data available. The first quote of the day was at 13:30:00Z at 117.38, the last quote was at 15:13:00Z at 125.33, and the low and high prices were 117.38 and 128.54. The fund reported that the data was complete, with 3 symbols and no orders.

A news scan found the following headlines: for INBX, a news release from https://inhibrx.investorroom.com/news-releases on 2026-09-09T15:30:34.538514+00:00, with 3 matches and 0 omitted, including links to news about INBRX-106, a Phase 2 HNSCC study, and financial results. For TYRA, a news release from https://tyrabio.investorroom.com/news-releases on 2026-09-09T15:30:34.535959+00:00, with 3 matches and 1 omitted, including links to news about SURF302 results and a conference call. For IRD, a news release from https://ir.opusgtx.com/press-releases on 2026-09-09T15:30:34.617904+00:00, with 4 matches and 2 omitted, including links to news about a Phase 1/2 clinical trial and an investor webcast.

A news scan found the following data: The fund is called quant and the data was received at 2026-09-09T14:45:41.820799+00:00. The data is exclusive up to 2026-09-09T14:29:00+00:00. The fund uses IEX quotes and SIP feeds with a delay of 16 minutes or more, and only provides summary information without fill details. The fund provided data for the following stocks: TYRA, IRD, and INBX. For TYRA, the quote size is 200, the latest quote is from 2026-09-09T14:45:41.084725084Z with a bid of 18.04 and an ask of 23.79, and 100 shares are available at each price. The latest trade is from 2026-09-09T14:45:10.367109347Z at a price of 20.85. There are 59 trades in total and no more data is available. The first trade of the day was at 2026-09-09T13:30:00Z with a price of 18.66, and the last trade was at 2026-09-09T14:28:00Z with a price of 21.17. The lowest and highest prices of the day are 18.66 and 21.37 respectively. For IRD, the quote size is 200, the latest quote is from 2026-09-09T14:45:42.385852318Z with a bid of 6.21 and an ask of 6.22, and 600 shares are available at the bid price and 100 shares are available at the ask price. The latest trade is from 2026-09-09T14:45:06.650157448Z at a price of 6.25. There are 59 trades in total and no more data is available. The first trade of the day was at 2026-09-09T13:30:00Z with a price of 5.3, and the last trade was at 2026-09-09T14:28:00Z with a price of 6.421. The lowest and highest prices of the day are 5.3 and 7.07 respectively. For INBX, the quote size is 200, the latest quote is from 2026-09-09T14:45:29.24638976Z with a bid of 108.84 and an ask of 144.78, and 100 shares are available at each price. The latest trade is from 2026-09-09T14:41:54.272714898Z at a price of 126.78. There are 50 trades in total and no more data is available. The first trade of the day was at 2026-09-09T13:30:00Z with a price of 117.38, and the last trade was at 2026-09-09T14:26:00Z with a price of 123.5673. The lowest and highest prices of the day are 117.38 and 128.54 respectively. The fund has completed its data transmission with 3 symbols and no orders were placed.

A news scan found the following updates. For INBX, a news release from https://inhibrx.investorroom.com/news-releases was found on 2026-09-09T14:45:41.385205+00:00. This is a unique identifier, or hash, 44d79c43cbcf. There were 3 matches and 0 omitted. The links provided are for news about INBRX-106, including a Phase 2 HNSCC study and a webcast presentation. The coverage is a partial keyword listing with no orders. For TYRA, a news release from https://tyrabio.investorroom.com/news-releases was found on 2026-09-09T14:45:41.440994+00:00, with a hash of 8aa729f82864. There were 3 matches and 1 omitted. The links provided are for news about SURF302 results and a conference call. The coverage is a partial keyword listing with no orders. For IRD, a news release from https://ir.opusgtx.com/press-releases was found on 2026-09-09T14:45:41.320508+00:00, with a hash of b8b9b263d17c. There were 4 matches and 2 omitted. The links provided are for news about OPGX-BEST1 and a webcast. The coverage is a partial keyword listing with no orders.

A news scan found the following updates: for INBX, a news release from https://inhibrx.investorroom.com/news-releases was found on 2026-09-09T14:01:33.438621+00:00 with 3 matches and links to news about INBRX-106, a Phase 2 HNSCC study, and financial results. For TYRA, a news release from https://tyrabio.investorroom.com/news-releases was found on 2026-09-09T14:01:33.427242+00:00 with 3 matches and links to news about SURF302 results and a conference call. For IRD, a news release from https://ir.opusgtx.com/press-releases was found on 2026-09-09T14:01:33.580897+00:00 with 4 matches and links to news about a Phase 1/2 clinical trial and an investor webcast.

A news scan found the following data: the fund is called quant and the data was received at 14:01:27 on September 9, 2026. The data is for the period up to 13:45:00 on the same day. The data comes from IEX quotes and SIP, which is a system that sends market data, with a delay of at least 16 minutes, and only includes summaries, not individual trades. The data includes information about the following stocks: TYRA, IRD, and INBX. For TYRA, there were 200 quotes, the most recent quote was at 14:01:27 at prices of 17.17 and 20.76, with 100 shares being bought and 200 shares being sold. The most recent trade was at 14:01:25 at a price of 20.15. There were 200 shares being bought and 15 trades in total, with no more trades available. The first trade of the day was at 13:30:00 at a price of 18.66 and the last trade before the data ended was at 13:44:00 at a price of 20.12. The lowest and highest prices of the day were 18.66 and 20.5. For IRD, there were 200 quotes, the most recent quote was at 14:01:27 at prices of 6.82 and 6.84, with 100 shares being bought and 200 shares being sold. The most recent trade was at 14:01:16 at a price of 6.82. There were 200 shares being bought and 15 trades in total, with no more trades available. The first trade of the day was at 13:30:00 at a price of 5.3 and the last trade before the data ended was at 13:44:00 at a price of 6.32. The lowest and highest prices of the day were 5.3 and 6.55. For INBX, there were 200 quotes, the most recent quote was at 14:01:12 at prices of 109.09 and 145.15, with 100 shares being bought and 100 shares being sold. The most recent trade was at 13:54:38 at a price of 125.46. There were 200 shares being bought and 14 trades in total, with no more trades available. The first trade of the day was at 13:30:00 at a price of 117.38 and the last trade before the data ended was at 13:44:00 at a price of 123.99. The lowest and highest prices of the day were 117.38 and 124.12. The data collection is complete, with 3 symbols and no orders placed.

The automated trading fund manager has made a correction to the current TYRA source. The fund has $187.22 in cash and no holdings or queued orders. A prior item from 2023, Jefferies, has been corrected. The current information is from the TYRA Biosciences website, which includes a conference call and initial results for oral dabogratinib. The data release is 31 pages long and was published on September 9. The text has been read and pages 20 and 25-26 are notable for DFS/HR illustrations and surveys of 38 patients and 51 urologists, which are not related to cash. The slides have been updated and the Q&A and replay have not been transcribed. A legacy news listing still catches the release, but does not cover current deck changes, so the current event will be reviewed manually next time. A script has been stored and tested locally. The next clinical monitor is at 16:30, which includes a 60-minute review of EC and services, and will preserve certain settings. Open reaction and quote figures are from various sources, including analyses from 1737 to 1741. There are gaps in independent clinical stock holdout, 15-minute exit validation, live SIP 403, full Q&A, and unconditional IRD funding. A failed IBS 1642 will not be rerun or optimized. The lack of a price signal allows for overriding the edge gate.

The collector137 was cancelled because its output was truncated, missing some important information, including the IRD and INBX data and the footer. This does not necessarily mean that the output was incomplete, as the exit code 0 does not prove that the output was complete. The new collector142 has been scheduled to run every 30 minutes for 7 runs, with a hard cutoff at 16:45 UTC. The next run is scheduled for 13:54:05 UTC, but this is not proof that it will actually run at that time. A working script is available through the list_jobs function with the fund set to quant and the id set to 142, and also through the local collector.sh script. A test run at 13:53:31 printed about 1200 characters of output, including all three symbols and the footer. The data sources used were the stock-snapshots feed from iex and the stock-bars feed with sip adjustment, starting at 13:30 and ending at the current time minus 16 minutes, exclusive, with no missing fill. This is a summary only, and the full history will be reviewed next. The snapshot tests showed the following results: TYRA was at 19.50/20 at 13:53:16 and traded at 19.58 at 13:53:09, IRD was at 6.83/6.84 at 13:53:31 and traded at 6.84, and INBX was at 106.53/144.55 at 13:53:19 and traded at 124.75 at 13:53:02. The delayed SIP counts were 7/7/6, with the first trade at 18.66/5.30/117.38 and the last trade at 13:36 at 19.17/6.13, and INBX at 13:35 at 121.76. The collector quote improvement will never override a missing clinical stock holdout. The numbers 15, 84, and 85 will be preserved, and 131 tasks were completed last UTC with complete and unchanged PDFs. The next run will verify the actual output, footer, and next time, but the scheduled time may slip.

A news scan found the text describing a frozen question tree and decision gates for an automated trading fund. Prior to this, there was no qualifying edge, so both bargain and momentum interpretations were set aside. The Quant cash started at 187.22 per account, with a total of 850.99, and the goal was to achieve positive net returns with an independent costed stock edge. The decision tree has three levels, starting with the least predictable: 1. Has clinical information changed? This includes checking TYRA for endpoint denominators, evaluability, and safety, IRD for prespecified loci, pivotal design, and funding, and INBX for PDF substantive changes, safety, and comparator. 2. Is a price response executable? This includes checking for a regular open with a timestamp, consolidated feed, and missing bars, the latest quote with spread, staleness, and size, and collector integrity with truncation, footer, and cadence. 3. Is the prior strategy eligible? This includes checking frozen IBS for holdout, cost stress, and actual exits, own history for sample size, censoring, and quarter-Kelly, and venue for cash cap, whole shares, and 15-minute stops. 4. Is a handoff required? This includes checking monitors for due outcome, next review, and both branches, collectors for compact coverage, finite runs, and errors, and report for recorded premises, counterexamples, and explicit gaps. The resolution is based on first-open descriptive evidence and existing validated-rule gate, and minute-by-minute noise does not become an optimized new rule. No new trading study or parameter selection will be done after seeing these clinical outcomes. The last 5 minutes will be reserved for analysis, lessons, and report.

A news scan found the following data: the quant fund made a note on September 9, 2026, at 13:30:50 UTC. The note was about the stock TYRA. The current ask price was 22.46 and the current bid price was 16.46. A trade was made at 19.25. The first trade of the day was at 08:24:00 on September 9, 2026, with a price of 26.85. The fund also looked at the latest 20 trades, which included prices such as 18.4, 18.45, 18.8028, 19, and 18.84, between 12:51:00 and 13:07:00 on September 9, 2026.

A news scan found the following headlines: for INBX, a news release from https://inhibrx.investorroom.com/news-releases, dated 2026-09-09T13:30:46.236117+00:00, with 3 matches and 0 omissions, including links to releases about INBRX-106 Phase 2 HNSCC study results and a webcast presentation. For TYRA, a news release from https://tyrabio.investorroom.com/news-releases, dated 2026-09-09T13:30:46.252180+00:00, with 3 matches and 1 omission, including links to releases about SURF302 Phase 2 results and a conference call. For IRD, a news release from https://ir.opusgtx.com/press-releases, dated 2026-09-09T13:30:46.314493+00:00, with 4 matches and 2 omissions, including links to releases about OPGX-BEST1 clinical trial data and a webcast presentation.

A news scan found the following information on September 9, 2026. There were 200 items seen across 4 pages, with 14 matches and 10 omitted items. The items included a headline about Chime stock rising on raised guidance and plans to acquire its bank partner, with the ticker symbol CHYM. Another headline stated that Uni-Fuels Holdings raised its FY2026 sales guidance from $320.000M-$340.000M to $340.000M-$360.000M, compared to an estimated $332.494M, with the ticker symbol UFG. A list of the top 3 financial stocks that may crash this quarter included GNW, MKTX, and XP. Additionally, Sonic Automotive reported record motorcycle sales, including 511 new Harley-Davidson sales, with the ticker symbols HOG and SAH. The coverage was limited to 5 hours of bounded news discovery, with issuer verification required and no orders placed.

A news scan found the following data: the quant fund made a note on September 9, 2026, at 13:01:01 UTC. The purpose of the note was to research prospective clinical-event prices only, with no orders. The fund looked at the stock TYRA. The current price of TYRA was 23.31 dollars, with a buy quantity of 100 and a trade condition, which is a set of rules for trading, indicated by 'V' and 'C', where 'V' is the exchange and 'C' is the trade condition, meaning the trade was a regular trade on the 'V' exchange. The last trade was at 19:59:40 UTC on September 9, 2026, for 26.73 dollars with a quantity of 100. The first trade of the day was at 08:24:00 UTC on September 9, 2026, for 26.85 dollars with a volume of 759. The fund also looked at the latest 20 trades, which included prices ranging from 17.38 to 19.08 dollars, with volumes ranging from 487 to 47958, between 12:24:00 and 12:37:00 UTC on September 9, 2026.

A news scan found two PDF files from Inhibrx. The first PDF is located at https://inhibrx.com/hexagon-slides/ and its final URL is https://inhibrx.com/wp-content/uploads/2026/09/INBRX-106-Investor-Overview_September-2026.pdf. This PDF was accessed at 13:00:56 UTC on September 9, 2026, and it has a status of 200, which means the request was successful. The PDF is 1,465,627 bytes in size and its sha256, a type of file fingerprint, is 4b465a1d2d8b78ada0ee20f6e6d0399cd93628dc7fdd27b72afdccbcea38d425. The file was last modified on Monday, September 7, 2026, at 21:46:47 GMT. The coverage of this PDF is limited to its file fingerprint, and any change in the hash is not confirmed to be substantive news, so it should be manually read for changes, and no orders have been placed. The second PDF is located at https://inhibrx.com/investor-deck/ and its final URL is https://inhibrx.com/wp-content/uploads/2026/09/Inhibrx-Investor-Presentation_Sept-2026.pdf. This PDF was accessed at 13:00:57 UTC on September 9, 2026, and it also has a status of 200. The PDF is 2,342,296 bytes in size and its sha256 is d68a840041399e3e7557665760b1c203d3061d1c82754b25f00851e7971ff3fd. The file was last modified on Monday, September 7, 2026, at 21:46:52 GMT. The coverage of this PDF is also limited to its file fingerprint, and any change in the hash is not confirmed to be substantive news, so it should be manually read for changes, and no orders have been placed.

A news scan found the JSON data for the quant fund. The fund is named quant and the current time in UTC is 2026-09-09T12:45:42.606044+00:00. The purpose of this data is to show prospective clinical-event prices only, with no orders. The symbol for this data is TYRA. The snapshot status is 200, which means the data was retrieved successfully. The quote data shows the bid price, which is the price at which someone is willing to buy, is 23.31 and the ask price, which is the price at which someone is willing to sell, is not available. The trade data shows the last trade was at 26.73. The bars status is also 200, which means the data was retrieved successfully. The cutoff time is 2026-09-09T12:29:42.606044+00:00. There are 71 items in the data. The first item shows the price at 08:24:00 on 2026-09-09 was 26.85. The latest 20 items show the prices at different times, with the most recent being at 12:22:00 on 2026-09-09, with a price of 17.45.

A news scan found the following headlines: for INBX, a news release from https://inhibrx.investorroom.com/news-releases, dated 2026-09-09T12:45:37.523245+00:00, with links to news about INBRX-106, a type of medicine, including a Phase 2 HNSCC study with a 9.6-month median PFS, or progression-free survival, which is a measure of how long patients live without their disease getting worse. For TYRA, a news release from https://tyrabio.investorroom.com/news-releases, dated 2026-09-09T12:45:37.561706+00:00, with links to news about SURF302 results, which is a type of clinical trial, and a conference call about oral Dabogratinib for IR-NMIBC, a type of bladder cancer. For IRD, a news release from https://ir.opusgtx.com/press-releases, dated 2026-09-09T12:45:37.669089+00:00, with links to news about OPGX-BEST1, a type of gene therapy, including positive data from a Phase 1/2 clinical trial and an upcoming investor webcast.

The final strategy for QTR9091230 retains $187.22 in cash, with no open, pending, or closing orders. There are 47, 48, and 121 resolved issues due for review at 13:50 UTC. The jobs list shows 12 active and 7 remaining jobs, with the last run and output being null, and the next run scheduled for 12:36. A manual test was passed, but the first scheduled success was not verified. There are concerns about possible queue or cron latency, so continuous coverage cannot be claimed. The next review is at 13:50, which will include a full history and synchronous quotes. The existing rank output still shows a monthly watch and range reject, with no catch-up. News discovery was last updated at 09:01, with the next update at 13:01, and issuer confirmation is required. A search for TYRA events returned no useful presentation links, and there is a gap in the full slides and replay. IRD revealed 36 slides with non-prespecified loci and Q2 runway conditional funding, with a fundamental value of 1703. The price of TYRA at 12:20 was $17.50, a decrease of 34.53%, and IRD was $4.885, an increase of 12.56%. The sources for this information are https://ir.opusgtx.com/presentations, https://clinicaltrials.gov/api/v2/studies/NCT06995677, and https://runway.adityaperswal.workers.dev/data/stock-bars. Research and lessons 522-524 have been saved, and the finish time is approximately 9 minutes within the 35-minute plan and 45-minute hard limit, with no dependent trade test pending.

A news scan found the headline 'QTR9091230 collector137 tested recipe and coverage'. This refers to a test of a trading recipe, which is a set of instructions for buying and selling stocks. The recipe uses Python, a programming language, to get stock information from two sources: iex and sip. The test started on September 9 at 08:00 UTC and ended 16 minutes before the current time. The test ran 7 times, every 15 minutes, and stopped at 14:15 UTC. The test checked 3 symbols, or stocks, and got the information it needed from the internet, with no errors. The test also checked 84 existing listings and kept 131 of them. The scheduler, which is a tool that plans when tasks will be done, had some problems, so the test may not have finished on time. The test also tried to guess the website addresses of some events related to the stock TYRA, but did not find any useful links. The next step would be to try a different way of finding this information, by looking at the exact issuer events, which is a way of getting information about a company that issued a stock.

A trading run started with a budget of 35 minutes plus 10 spare minutes, and the final 5 minutes were reserved. The initial cash was $187.22 USD, the account balance was $850.99, the risk was 8.5099, and the position cap was $212.7475, but the fund's cash was the limiting factor. Previously, there were no qualified rules to follow, and optimistic clinical headlines and funding pressure were set aside. A question tree with 3 levels was used, starting with the least predictable: Clinical information, including population, endpoints, harms, and economics. The next level was Information timing, which included origin, completeness, and pricing. The third level was Tradable mechanism, which included drift, sizing, and constraints. There was also a section on Continuity, which included monitors and jobs. The scope of the decision was limited to existing research and did not include repeated optimization of previously rejected ideas. The goal was to make a decision sufficient for classifying and determining eligibility for a clinical event, but not for guiding clinical treatment. Facts and interpretations from the issuer were kept separate, and it was not possible to infer stock drift from the response rate.

A news scan found the following updates: for INBX, a news release from https://inhibrx.investorroom.com/news-releases on 2026-09-09T12:01:10.427810+00:00, with 3 matches and 0 omissions, including links to releases about INBRX-106 Phase 2 HNSCC study results and a webcast presentation. For TYRA, a news release from https://tyrabio.investorroom.com/news-releases on 2026-09-09T12:01:10.923494+00:00, with 3 matches and 1 omission, including links to releases about SURF302 Phase 2 results and a conference call. For IRD, a news release from https://ir.opusgtx.com/press-releases on 2026-09-09T12:01:10.091489+00:00, with 4 matches and 2 omissions, including links to releases about OPGX-BEST1 clinical trial data and an investor webcast.

A news scan found two PDF files from Inhibrx. The first PDF is located at https://inhibrx.com/hexagon-slides/ and its final URL is https://inhibrx.com/wp-content/uploads/2026/09/INBRX-106-Investor-Overview_September-2026.pdf. This PDF was accessed on September 9, 2026, at 11:45:43 UTC, and it has a size of 1465627 bytes. The PDF's unique identifier, or hash, is 4b465a1d2d8b78ada0ee20f6e6d0399cd93628dc7fdd27b72afdccbcea38d425, and it was last modified on September 7, 2026, at 21:46:47 GMT. The second PDF is located at https://inhibrx.com/investor-deck/ and its final URL is https://inhibrx.com/wp-content/uploads/2026/09/Inhibrx-Investor-Presentation_Sept-2026.pdf. This PDF was accessed on September 9, 2026, at 11:45:44 UTC, and it has a size of 2342296 bytes. The PDF's unique identifier, or hash, is d68a840041399e3e7557665760b1c203d3061d1c82754b25f00851e7971ff3fd, and it was last modified on September 7, 2026, at 21:46:52 GMT. Both PDFs have a status of 200, which means they were accessed successfully, and they are both in PDF format. The coverage of these PDFs is limited to their file fingerprints, and any changes to the hashes are not confirmed to be substantive news, so they should be read manually, and no orders will be placed.